MAPT and Alzheimer disease: In contrast, a recent study revealed that SUMO1 immunoreactivity colocalized with hyper-phosphorylated Tau in the cortex and hippocampal CA1 region of post-mortem AD brains, whereas no signal was measured for aged-matched control brains (Luo et al., 2014).